Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited
- PMID: 11762804
- DOI: 10.1023/a:1012504904713
Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited
Abstract
Peritonitis carcinomatosa, indicating the presence of malignant cells in the peritoneal cavity, is a well-known complication of malignant disease. As a result, so-called malignant ascites develops. Malignant ascites is a debilitating condition for which no effective anti-tumor therapy is available. Frequent draining may be necessary to relieve pain and discomfort. Most studies regarding malignant ascites focus on diagnosis and treatment. In this paper. we will address the subject from a pathophysiologic perspective, using the characteristics of malignant ascites, Starling's equation of capillary forces, and recent knowledge regarding biologically active peptides produced by tumor cells. Following this approach. apart from decreased lymphatic ascites absorption, increased net capillary fluid-production can be identified as a contributing feature of ascites formation. The increased net filtration is due to an increase of overall capillary membrane-surface, increased capillary permeability and a subsequent increase of intraperitoneal protein concentration leading to increased intraperitoneal oncotic pressure. This sequence might be the result of biologically active peptides produced by tumor cells such as vascular endothelial growth factor and basic fibroblast growth factor. Interference with these mediators may serve as a target in future therapeutic strategies.
Similar articles
-
Ascites revisited: a novel role for tamoxifen.Eur J Surg Oncol. 1997 Dec;23(6):570. doi: 10.1016/s0748-7983(97)93461-2. Eur J Surg Oncol. 1997. PMID: 9484934 No abstract available.
-
Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.Cancer Res. 1995 Jan 15;55(2):360-8. Cancer Res. 1995. PMID: 7812969
-
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors.Br J Cancer. 2001 Aug 17;85(4):584-9. doi: 10.1054/bjoc.2001.1936. Br J Cancer. 2001. PMID: 11506500 Free PMC article.
-
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255. Hum Reprod Update. 1997. PMID: 9322101 Review.
-
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.J Clin Oncol. 2002 Nov 1;20(21):4368-80. doi: 10.1200/JCO.2002.10.088. J Clin Oncol. 2002. PMID: 12409337 Review.
Cited by
-
Functional vascular anatomy of the peritoneum in health and disease.Pleura Peritoneum. 2016 Sep 1;1(3):145-158. doi: 10.1515/pp-2016-0015. Epub 2016 Oct 4. Pleura Peritoneum. 2016. PMID: 30911618 Free PMC article. Review.
-
Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis.J Belg Soc Radiol. 2020 Jan 30;104(1):8. doi: 10.5334/jbsr.1940. J Belg Soc Radiol. 2020. PMID: 32025624 Free PMC article.
-
Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*: A Prospective Substudy of a Randomized Controlled Trial.Medicine (Baltimore). 2015 Dec;94(49):e2108. doi: 10.1097/MD.0000000000002108. Medicine (Baltimore). 2015. PMID: 26656336 Free PMC article. Clinical Trial.
-
The glycosphingolipid P₁ is an ovarian cancer-associated carbohydrate antigen involved in migration.Br J Cancer. 2014 Oct 14;111(8):1634-45. doi: 10.1038/bjc.2014.455. Epub 2014 Aug 28. Br J Cancer. 2014. PMID: 25167227 Free PMC article.
-
Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion.Oncotarget. 2017 May 23;8(21):35262-35271. doi: 10.18632/oncotarget.13064. Oncotarget. 2017. PMID: 27823984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials